Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase II
Otonomy (OTIC) Reports Phase IIb Topline Data for OTO-104 in Meniere's Disease 5/22/2015 7:47:38 AM
Otonomy (OTIC) Plunges After Near-Miss Stage IIb Trial for Ear Drug 5/21/2015 4:37:02 PM
Complete Data From RegeneRx Biopharmaceuticals, Inc. (RGRX) Phase II Dry Eye Trial Published In Current Issue Of Clinical Ophthalmology 5/22/2015 6:47:17 AM
Galena Biopharma  (GALE) To Present GALE-401 (Anagrelide Controlled Release) Phase II Clinical Trial Data At The European Hematology Association 20th Congress 5/22/2015 6:10:31 AM
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial 5/20/2015 6:37:38 AM
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each 5/20/2015 6:44:18 AM
OrthoTrophix Completed Subject Enrollment Of The Phase 2 Clinical Trial Of A New Cartilage Repair Therapeutic For Knee Osteoarthritis 5/21/2015 1:23:59 PM
Theravance Biopharma Presents Additional Positive Phase 2b Study Data On TD-4208 For Treatment Of COPD At American Thoracic Society 2015 International Conference 5/21/2015 12:14:56 PM
Amarantus BioSciences, Inc. Enters Into CRO Agreement With Chiltern International Ltd. To Commence Phase IIb Clinical Development Of Eltoprazine In Parkinson's Disease Levodopa-Induced Dyskinesia 5/21/2015 11:01:01 AM
Vical Incorporated (VICL) Announces Completion Of Enrollment In Phase II Clinical Trial Of Investigational CMV Vaccine In Kidney Transplant Recipients 5/21/2015 10:58:56 AM
EMD Serono, Inc. Release: Rebif (interferon beta-1a) Data At CMSC Annual Meeting Highlights Clinical And MRI Predictors For Long Term Outcomes 5/21/2015 8:05:35 AM
CytRx Corporation (CYTR) Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results In Glioblastoma Multiforme (Brain Cancer) 5/21/2015 8:35:36 AM
ICC Cohort Of Delcath Systems (DCTH)'s Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 5/21/2015 6:41:35 AM
Investors Rejoice as bluebird bio (BLUE) Plots Road to First-Ever U.S. Gene Therapy Approval 5/19/2015 8:05:37 AM
Ischemix Announces That Safety Review Committee For CARIN Trial Recommends Phase 2a Study To Continue As Planned 5/20/2015 12:14:33 PM
1234567
//-->